INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Jan 10, 2012 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,128 | -- | -- |
Feb 20, 2015 |
Director
Trans History: 524
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 18,174 | $423.31 | 48,250 |
Aug 06, 2014 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 18,301 | $336.11 | 28,014 |
May 14, 2020 |
EVP General Counsel and Secret
Trans History: 181
|
EVP General Counsel and Secret | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,311 | $59.20 | 32,749 |
May 14, 2020 |
EVP General Counsel and Secret
Trans History: 181
|
EVP General Counsel and Secret | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,311 | -- | -- |
Jun 02, 2017 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 18,311 | $483.04 | 23,637,036 |
Mar 16, 2015 |
SVP General Counsel and Secret
Trans History: 181
|
SVP General Counsel and Secret | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,311 | $59.20 | 28,311 |
Mar 16, 2015 |
SVP General Counsel and Secret
Trans History: 181
|
SVP General Counsel and Secret | Form 4 | Open market or private sale of non-derivative or derivative security | 18,311 | $450.00 | 10,000 |
Mar 16, 2015 |
SVP General Counsel and Secret
Trans History: 181
|
SVP General Counsel and Secret | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,311 | -- | 54,933 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 660
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,311 | $10.56 | 22,198 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.